Ralf Trauzeddel

Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

Sergio Davì, Francesca Minoia, Angela Pistorio et al. · Arthritis & Rheumatology · 2014 · 116 citations · Full text

Medicine, Immunology, Pathology +16

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

Nicolino Ruperto, Hermine I. Brunner, Pierre Quartier et al. · Annals of the Rheumatic Diseases · 2018 · 110 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

Gerd Horneff, Anna Carina Schulz, Jens Klotsche et al. · Arthritis Research & Therapy · 2017 · 109 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Efficacy and Safety of Etanercept in Patients With the Enthesitis‐Related Arthritis Category of Juvenile Idiopathic Arthritis: Results From a Phase III Randomized, Double‐Blind Study

Gerd Horneff, Ivan Foeldvari, Kirsten Minden et al. · Arthritis & Rheumatology · 2015 · 72 citations

Medicine, Clinical Sciences, Pharmacotherapy +12

Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

Francesca Minoia, Francesca Bovis, Sergio Davì et al. · The Journal of Pediatrics · 2017 · 68 citations

Medicine, Hematology, Pathology +9